MAPK3 and obstructive sleep apnea syndrome: Exposure to low concentrations of non-selective adrenergic agonists EPI and NOR resulted in increased OSA growth and activation of the ERK1/2-MAPK signaling pathway, in accordance to previously reported data21,22.